Baro, Alfredo G.
HRN: 16-45-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/07/2022
11/13/2022
IV
500mg
Q8
Incarcerated Indirect Inguinal Hernia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes